Search
OTL-102
go.drugbank.com/drugs/DB18642ExperimentalIt is being investigated for the treatment of X-linked chronic granulomatous disease. … OTL-102 consists of autologous CD34+ enriched cells that contain hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox gene.
Synonyms: Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox geneIDM-1
go.drugbank.com/drugs/DB05292ExperimentalIDM-1 is IDM’s most advanced antibody-based Cell drug for the treatment of cancer. … It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific anti-HER-2/neu antibody developed by Medarex Inc.
MF-300
go.drugbank.com/drugs/DB32060InvestigationalAs a potential candidate for the treatment of sarcopenia, it has undergone phase 1 studies to evaluate safety, tolerability, and PK/PD characteristics.[A275368,L54983]
Omoconazole
go.drugbank.com/drugs/DB13684ExperimentalCategories: Antifungals for Topical Use, Antifungals for Dermatological UseSulbenicillin
go.drugbank.com/drugs/DB13693InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseSulfamethoxypyridazine
go.drugbank.com/drugs/DB13773InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseMetampicillin
go.drugbank.com/drugs/DB13836ExperimentalMetampicillin is a penicillin antibiotic prepared by the reaction of ampicillin with formaldehyde. It is hydrolysed in aqueous solution to form ampicillin.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseFenticonazole
go.drugbank.com/drugs/DB13434InvestigationalFenticonazole has a broad spectrum of antimycotic activity against dermatophytes and yeasts.[A275048]
Categories: Antifungals for Topical Use, Antifungals for Dermatological UseAmobarbital
go.drugbank.com/drugs/DB01351ApprovedIllicitA barbiturate with hypnotic and sedative properties (but not antianxiety). … Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
VA-MENGOC-BC®
go.drugbank.com/drugs/DB15800ExperimentalAs there already exists a polysaccharide-based vaccine against meningococcal disease originating from serogroups A,C,W135, and Y, this vaccine was created for use against serogroups B and C. … As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.